A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism

Abroad (travel likely)RecruitingPHASE2

Conditions

Primary Aldosteronism

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
Contact: Principal Investigator (Qifu Li)
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Contact: Principal Investigator (Guijun Qin)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism

Primary Aldosteronism · Primary Aldosteronism Due to Aldosterone Producing Adenoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism

Primary Aldosteronism

Abroad (travel likely)RecruitingPHASE2

Calgary, Canada

Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldosterone and Renin Activity in the Diagnosis of Primary Aldosteronism by Captopril Test

Primary Aldosteronism

Abroad (travel likely)Recruiting

Beijing, China

Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism

Primary Aldosteronism · Endocrine Hypertension

Abroad (travel likely)Recruiting

Dhaka, Bangladesh